Literature DB >> 20504721

Generalized molecular defects of the neuromuscular junction in skeletal muscle of the wobbler mutant mouse.

J Melki1, B Blondet, M Pinçon-Raymond, P Dreyfus, F Rieger.   

Abstract

Available models of motorneuron disease that occur naturally in animals provide a useful approach to study human motorneuron disease. The wobbler mutant mouse displays a hereditary lower motorneuron disease which leads to progressive partial denervation of skeletal muscle and, at the same time, axonal regeneration with attempted reinnervation. In order to determine the consequences of these processes at the neuromuscular level, we undertook a study of key molecular components of the neuromuscular junction in wobbler mice. Increased levels of acetylcholine-receptor (AChR) and neural cell adhesion molecule (N-CAM) in wobbler muscle, together with an intense axon sprouting, suggest a complex denervation-reinnervation phenomenon. Furthermore, the appearance of ectopic clusters of AChR, spatially related with regrowth of axons, suggests ectopic formation of new synaptic areas, while, at the same time, some old synaptic sites fail to be reinnervated. Finally, 90% of wobbler neuromuscular contacts present a reduced acetylcholinesterase activity and a lack of N-CAM, which suggests a generalized defect of the mutant neuromuscular junction. These observed abnormalities may well be the consequence of a specific motorneuron defect.

Entities:  

Year:  1991        PMID: 20504721     DOI: 10.1016/0197-0186(91)90176-e

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.

Authors:  Brigitte Blondet; Gilles Carpentier; Arnaud Ferry; Arnaud Chatonnet; José Courty
Journal:  J Histochem Cytochem       Date:  2010-08-30       Impact factor: 2.479

Review 2.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.